Search research articles
Contact Us
Filters
Showing results (451-460 of 481) with videos related to
Page
of 49
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
David Milewski, Hyun Jung, G Thomas Brown, et al.
BJU International
|
January 19, 2016
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Yang-Min Ning, et al.
Blood
|
February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
Cancer Cell
|
May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Sarah Jenkins, Wei Zhang, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2020
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
Mark Roschewski, Kieron Dunleavy, Jeremy S Abramson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer
Shivaani Kummar, Amit M Oza, Gini F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 481) with videos related to
Sort By:
Page
of 49
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
Nirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
David Milewski, Hyun Jung, G Thomas Brown, et al.
BJU International
|
January 19, 2016
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer
Ravi A Madan, Fatima H Karzai, Yang-Min Ning, et al.
Blood
|
February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai, David VanderWeele, Ravi A Madan, et al.
Cancer Cell
|
May 30, 2017
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
Sarah Jenkins, Wei Zhang, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 27, 2020
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
Mark Roschewski, Kieron Dunleavy, Jeremy S Abramson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2015
Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer
Shivaani Kummar, Amit M Oza, Gini F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Page
of 49